Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL31599597 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL2513582 | 1.00 | — | — | |
| SCHEMBL29352170 | 0.94 | — | — | |
| Hydrochloric Acid SCHEMBL200261 | 0.88 | — | — | |
| Hydrochloric Acid SCHEMBL21351719 | 0.88 | — | — | |
| Hydrochloric Acid SCHEMBL4002029 | 0.88 | — | — | |
| Hydrochloric Acid SCHEMBL21300485 | 0.88 | — | — | |
| Hydrochloric Acid SCHEMBL22041939 | 0.88 | — | — | |
| Hydrochloric Acid SCHEMBL288077 | 0.88 | — | — | |
| Hydrochloric Acid SCHEMBL9780549 | 0.88 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9315525-B2 | Synthetic route for the preparation of α-amino boronic acid derivatives via substituted alk-1-ynes | LEK PHARMACEUTICALS D.D. (SI) | 2016-04-19 | — | — | US | claimed |
| EP-2427419-B1 | VINYL ESTER PRODUCTION FROM ACETYLENE AND CARBOXYLIC UTILIZING HOMOGENEOUS CATALYST | CELANESE INT CORP (US) | 2014-06-18 | — | — | EP | claimed |
| US-12410153-B2 | Compounds, compositions and methods | AVALO THERAPEUTICS, INC. (US) | 2025-09-09 | — | — | US | disclosed |
| WO-2024192064-A1 | COMPOUNDS AND COMPOSITIONS AS SMARCA2/4 DEGRADERS AND USES THEREOF | ONCOPIA THERAPEUTICS, INC. D/B/A/ PROTEOVANT THERAPEUTICS, INC. (US) | 2024-09-19 | — | — | WO | disclosed |
| US-20230257363-A1 | COMPOUNDS, COMPOSITIONS AND METHODS | CERECOR INC. | 2023-08-17 | — | — | US | disclosed |
| US-11591314-B2 | Process for preparing tetrahydrocarbazole carboxamide compound | BRISTOL-MYERS SQUIBB COMPANY (US) | 2023-02-28 | — | — | US | disclosed |
| EP-3237399-B1 | COMPOUNDS, COMPOSITIONS AND METHODS | AVALO THERAPEUTICS INC (US) | 2022-11-30 | — | — | EP | disclosed |
| US-11479542-B2 | Compounds, compositions and methods | CERECOR, INC. (US) | 2022-10-25 | — | — | US | disclosed |
| US-11440926-B2 | Method for preparing aminopropylsilanes | WACKER CHEMIE AG (DE) | 2022-09-13 | — | — | US | disclosed |
| US-20210284666-A1 | METHOD FOR PREPARING AMINOPROPYLSILANES | WACKER CHEMIE AG (DE) | 2021-09-16 | — | — | US | disclosed |
| US-20210107892-A1 | COMPOUNDS, COMPOSITIONS AND METHODS | MERCK SHARP & DOHME LLC | 2021-04-15 | — | — | US | disclosed |
| EP-0863145-B1 | Sunscreen compositions | HOFFMANN LA ROCHE (CH) | 2003-10-01 | — | — | EP | disclosed |
| EP-0785198-B1 | Method for the preparation of optically active 3-hydroxyquinuclidine | LONZA AG (CH) | 2000-07-05 | — | — | EP | disclosed |
| US-5976512-A | SUN SCREENING AGENTS. | ROCHE VITAMINS INC. (US) | 1999-11-02 | — | — | US | disclosed |
| EP-0863145-A2 | Sunscreen compositions | F. HOFFMANN-LA ROCHE AG (CH) | 1998-09-09 | — | — | EP | disclosed |
| US-5744606-A | Process for the preparation of optically active 3-quinuclidinol | LONZA AG (CH) | 1998-04-28 | — | — | US | disclosed |
| EP-0512415-B1 | Process for the enantioselective synthesis of 2(R)-benzyl succanamide derivatives | HOECHST AG (DE) | 1997-08-06 | — | — | EP | disclosed |
| EP-0785198-A1 | Method for the preparation of optically active 3-hydroxyquinuclidine | LONZA AG (CH) | 1997-07-23 | — | — | EP | disclosed |
| US-5321139-A | Amination of phenylitaconic anhydride, catalytic reduction of formed amide; renin inhibitor | HOECHST AKTIENGESELLSCHAFT (DE) | 1994-06-14 | — | — | US | disclosed |
| EP-0512415-A2 | Process for the enantioselective synthesis of 2(R)-benzyl succanamide derivatives | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-11-11 | — | — | EP | disclosed |